Skip to main content
SpringerLink
Log in

Use of pharmacy claims databases to determine rates of medication adherence

  • Published:
Advances in Therapy Aims and scope Submit manuscript

Abstract

Failure to adhere to pharmaceutical therapy leads to poor clinical outcomes and substantially increased healthcare costs. Pharmacy claims databases contain all the information required to determine adherence to therapy for populations and individual patients, but extraction and analysis of these data are difficult and time-consuming. The Standardized Therapy Adherence Research Tool (START) converts pharmacy claims databases into a standardized format to rapidly obtain comprehensive adherence information that can be used to design interventions aimed at improving adherence rates.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Morris LS, Schulz RM. Patient compliance—an overview.J Clin Pharm Ther. 1992;17:283–295.

    CAS  PubMed  Google Scholar 

  2. Sackett DL, Snow JC. The magnitude of compliance and noncompliance. In: Haynes RB, Taylor DW, Sackett DL, eds.Compliance in Health Care. Baltimore, Md: Johns Hopkins University Press; 1979: 11–22.

    Google Scholar 

  3. Lassen LC. Patient compliance in general practice.Scand J Primary Health Care. 1998;7:179–180.

    Article  Google Scholar 

  4. Donovan JL. Patient decision making. The missing ingredient in compliance research.Int J Technol Assess Health Care. 1995;11:443–455.

    Article  CAS  PubMed  Google Scholar 

  5. Griffith S. A review of the factors associated with patient compliance and the taking of prescribed medicines.Br J Gen Pract. 1990;40:114–116.

    CAS  PubMed  Google Scholar 

  6. Urquhart J. Patient non-compliance with drug regimens: measurement, clinical correlates, economic impact.Eur Heart J. 1996;17(suppl A):8–15.

    PubMed  Google Scholar 

  7. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients.JAMA. 2002;288:455–461.

    Article  PubMed  Google Scholar 

  8. Shaw E, Anderson JG, Maloney M, Jay SJ, Fagan D. Factors associated with noncompliance of patients taking antihypertensive medications.Hosp Pharm. 1995;30:201–203, 206–207.

    CAS  PubMed  Google Scholar 

  9. Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review.J Clin Pharm Ther. 2001;26:331–342.

    Article  CAS  PubMed  Google Scholar 

  10. Rand CS, Wise RA. Measuring adherence to asthma medication regimens.Am J Respir Crit Care Med. 1994;149(2, pt 2):S69-S76; discussion S77–S78.

    CAS  PubMed  Google Scholar 

  11. Donovan JL, Blake DR. Patient non-compliance: deviance or reasoned decision-making?Soc Sci Med. 1992;34:507–513.

    Article  CAS  PubMed  Google Scholar 

  12. Miller LG, Liu H, Hays RD, et al. How well do clinicians estimate patients’ adherence to combination antiretroviral therapy?J Gen Intern Med. 2002;17:1–11.

    Article  PubMed  Google Scholar 

  13. Rumore MM, Feifer S, Rumore JS. New York City pharmacists and OBRA ′90: one year later.Am Pharm. 1995;NS35:29–34, 66.

    CAS  PubMed  Google Scholar 

  14. Hansen RW, Ranelli PL. Omnibus Budget Reconciliation Act of 1990 and voluntarism: logistic regression analysis of pharmacist responsibility.Ann Pharmacother. 1994;28:1020–1024.

    CAS  PubMed  Google Scholar 

  15. Brushwood DB. Pharmaco-legal considerations in the clinical use of decongestants.Pharmacotherapy. 1993;13(6, pt 2):135S-142S; discussion 143S–146S.

    CAS  PubMed  Google Scholar 

  16. Miller NH, Hill M, Kottke T, Ockene IS. The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals.Circulation. 1997;95:1085–1090.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Applications, Pfizer Pharmaceuticals Group, 10017, New York, NY

    David Day PhD (Sr. Director)

Authors
  1. David Day PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Day, D. Use of pharmacy claims databases to determine rates of medication adherence. Adv Therapy 20, 164–176 (2003). https://doi.org/10.1007/BF02850203

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02850203

Keywords

Search

Navigation